PBM
PSYENCE BIO (PBM)
NASDAQ
$3.03+$0.11 (+3.95%)
Price as of Jun 23, 2026 6:19 PM EDT
  • $7.1M
    Market Cap
  • -90.78%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
03/31/2026
03/31/2025
03/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
218,485
-54.81%
483,530
+499.89%
80,603
N/A
Research and Development Expense
-1.5M
+328.64%
-342,168
-64.16%
-954,593
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
892,264
-26.25%
1.2M
+116.86%
557,904
N/A
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-9,522
+2.72%
-9,270
N/A
N/A
N/A
Interest Income and Expense and Net
-9,522
+2.72%
-9,270
N/A
0
N/A
Total Nonoperating Income and Expense
9,522
+2.72%
9,270
+101.05%
-879,344
N/A
Income before Taxes
-6.9M
-785.56%
1.0M
+101.98%
-51.2M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-6.9M
-785.56%
1.0M
+101.98%
-51.2M
N/A
Net Income from Continuing Operations Applicable to Common
-6.9M
-785.56%
1.0M
+101.98%
-51.2M
N/A
Basic EPS and Net Income
-12.56
-339.69%
5.24
+167.01%
-7.82
N/A
Diluted EPS and Net Income
-12.56
-339.69%
5.24
+167.01%
-7.82
N/A
Basic Weighted Average Shares
552,282
+186.09%
193,043
-97.04%
6.5M
N/A
Diluted Weighted Average Shares
552,282
+186.09%
193,043
-97.04%
6.5M
N/A
Balance Sheet
Cash and Cash Equivalents
7.4M
+21.35%
6.1M
+736.78%
733,188
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.4M
+21.35%
6.1M
+736.78%
733,188
N/A
Total Current Assets
9.1M
+38.87%
6.6M
+482.27%
1.1M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
6,059
-45.39%
11,096
+102.22%
5,487
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
17.6M
+140.11%
7.3M
+546.23%
1.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
251,110
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1.2M
0.00%
1.2M
N/A
N/A
N/A
Total Liabilities
623,190
+4.85%
594,366
-95.09%
12.1M
N/A
Retained Earnings
-63.4M
+12.29%
-56.4M
-1.76%
-57.5M
N/A
Total Stockholders Equity
16.9M
+152.07%
6.7M
+161.26%
-11.0M
N/A
Total Shares Outstanding
2.3M
+303.73%
568,021
-95.76%
13.4M
N/A
Cash Flow
Cash from Operating Activities
-8.1M
+118.06%
-3.7M
+26.78%
-2.9M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-4.5M
+27,697.02%
-16,230
+183.39%
-5,727
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.0M
+52.57%
9.2M
+289.47%
2.4M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-55.75%
-332.76%
23.95%
N/A
N/A
N/A
Return on Equity
-58.62%
+23.13%
-47.61%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Cash Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow